Clinical Trial Update: Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether WO2085 Moisturising Cream is non-inferior to estriol 0.1% cream for vulvovaginal dryness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• Estriol 0.1% Cream (estriol)
• WO2085 Moisturising Cream

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Vulvovaginal Atrophy | Phase 4 | Status: COMPLETED